(Q33738963)

English

Effects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: a 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Effects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: a 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucoma (English)

1 reference

Europe PubMed Central

29 July 2017

1 reference

based on heuristic

inferred from title

author name string

Nicola Cardascia

1

1 reference

Europe PubMed Central

29 July 2017

Michele Vetrugno

2

1 reference

Europe PubMed Central

29 July 2017

Tiziana Trabucco

3

1 reference

Europe PubMed Central

29 July 2017

Francesco Cantatore

4

1 reference

Europe PubMed Central

29 July 2017

Carlo Sborgia

5

1 reference

Europe PubMed Central

29 July 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

29 July 2017

Current Therapeutic Research

1 reference

Europe PubMed Central

29 July 2017

64

1 reference

Europe PubMed Central

29 July 2017

389-400

1 reference

Europe PubMed Central

29 July 2017

7

1 reference

Europe PubMed Central

29 July 2017

Travoprost--a new prostaglandin analogue for the treatment of glaucoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Topical latanoprost and optic nerve head and retinal circulation in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Autoregulation of ocular blood flow during changes in intraocular pressure. Preliminary results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Effect of different antiglaucomatous drugs on ocular perfusion pressures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Control of retinal and choroidal blood flow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

21 June 2018

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: an open-label, uncontrolled, prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Effect of latanoprost on ocular hemodynamics and contrast sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Potential neuroprotective therapy for glaucomatous optic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053018

30 October 2018

Prevent Blindness America visual field screening study. The Prevent Blindness America Glaucoma Advisory Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0011-393X%2803%2900112-7

7 January 2021

Ocular blood flow changes with increased vascular resistance external and internal to the eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Latanoprost 0.005% in POAG: effects on IOP and ocular blood flow

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood flow in the human eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/24944390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0011-393X(03)00112-7

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33738963&oldid=1957210897"